15-min delayed · Aug 26, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for ADXN yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $4.20 current
Highest Target—
Average Target—
Lowest Target—
ADXN analyst recommendation trends
86420
Aug
Sep
Strong BuyBuyHoldSellStrong Sell
RATING
AUG
SEP
Strong Buy
0
0
Buy
1
1
Hold
0
0
Sell
0
0
Strong Sell
0
0
Total
1
1
As of Sep, 1 of 1 firms rate ADXN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ADXN EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect Addex Therapeutics Ltd to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —)., rising to $1.5M next year.
Top analysts covering Addex Therapeutics Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ADXN.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #294
Buy
$30.00+614.3% to target
Overall win rate
37%
+ Follow
ADXN stock forecast FAQ
Who is the most accurate analyst covering ADXN?+
Among analysts who currently cover ADXN, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #294). Their current call is Buy with a $30.00 target.
What is Addex Therapeutics Ltd's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts, rising to — the following year.
How much revenue is Addex Therapeutics Ltd expected to report next quarter?+
Consensus revenue is — (range — – —), growing to $1.5M next year.
Have analysts been upgrading or downgrading ADXN lately?+
As of Sep, 1 of 1 firms rate ADXN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ADXN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
